Injectable Platelet Rich Fibrin With Non Surgical Periodontal Therapy
NCT ID: NCT04070729
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2019-08-28
2020-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
120 periodontal patients will receive a scaling and root planing ( non surgical periodontal therapy). Equal number of patients will receive subgingival application of i-PRF, hyaluronic acid or placebo gel as the adjunction to non surgical therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Injectable Platelet Rich Fibrin in Periodontal Treatment
NCT06814418
Hyaluronic Acid 0.2% Application Enhanced Chronic Periodontitis Treatment in Non-surgical Phase
NCT04675385
Efficacy of Injectable Platelet-rich Fibrin Versus Platelet-Rich Plasma As Adjunctive to Scaling and Root Planning in Non-surgical Periodontal Therapy of Periodontitis Patients
NCT06685393
Evaluation of Repeated Injectable PRF Following SRP in Patients With Periodontitis
NCT07029035
The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6
NCT06968286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Negative control
Placebo gel
Placebo gel
Localized subgingival application
Test group 1
Hyaluronic acid gel
Hyaluronic acid gel
Localized subgingival application
Test group 2
injectable prf
Platelet rich fibrin
Localized subgingival application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo gel
Localized subgingival application
Hyaluronic acid gel
Localized subgingival application
Platelet rich fibrin
Localized subgingival application
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having minimum of 20 permanent teeth.
* They have not taken medication known to interfere with periodontal tissue health or healing in the preceding 6 months.
* Presence of periodontal pockets (≥5 mm) and clinicala ttachment level \> 5 mm.
Exclusion Criteria
* Clotting and Hematological disorders
* Patients with grade III mobility.
* Patients with smoking and alcohol consuming habit.
* Pregnant and lactating female.
* Medications influence on the gingival and periodontal tissues (like calcium channel blockers, or Long-term steroid use)
* The teeth with poor filling and ill fitted restorations
30 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Dental Sciences, Bareilly, Uttar Pradesh, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ASHISH AGARWAL
Clinical professor, institute of dental sciences, bareilly
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IEC/IDS50/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.